4//SEC Filing
Hwang Angela 4
Accession 0001225208-22-003664
CIK 0000078003other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:02 PM ET
Size
11.7 KB
Accession
0001225208-22-003664
Insider Transaction Report
Form 4
PFIZER INCPFE
Hwang Angela
Group President
Transactions
- Tax Payment
Common Stock
2022-02-26$50.64/sh−5,937$300,650→ 9,995 total - Exercise/Conversion
Stock Appreciation Rights
2022-02-26−12,716→ 0 totalExercise: $25.60From: 2022-02-26Exp: 2022-02-26→ Common Stock (12,716 underlying) - Exercise/Conversion
Common Stock
2022-02-26$25.60/sh+12,716$325,530→ 19,393 total - Tax Payment
Common Stock
2022-02-26$47.72/sh−3,461$165,159→ 15,932 total
Holdings
- 27,860(indirect: By Rule 16b-3 Plan)
Common Stock
- 8,532(indirect: By Spouse)
Common Stock
Footnotes (6)
- [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
- [F3]Price is the closing price of Pfizer common stock on February 25, 2022.
- [F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
- [F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
- [F6]The reporting person disclaims beneficial ownership of the shares held by spouse.
Documents
Issuer
PFIZER INC
CIK 0000078003
Entity typeother
Related Parties
1- filerCIK 0001725474
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:02 PM ET
- Size
- 11.7 KB